Author(s): Zahra Eftekhar | Fariba Yarandi | Narges Izadi-Mood | Parvaneh Rahimi-Moghaddam
Journal: Iranian Journal of Pharmacology and Therapeutics
ISSN 1735-2657
Volume: 5;
Issue: 1;
Start page: 81;
Date: 2006;
Original page
Keywords: Tamoxifen | Breast cancer | Endometrial cancer | Case report
ABSTRACT
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use.
Journal: Iranian Journal of Pharmacology and Therapeutics
ISSN 1735-2657
Volume: 5;
Issue: 1;
Start page: 81;
Date: 2006;
Original page
Keywords: Tamoxifen | Breast cancer | Endometrial cancer | Case report
ABSTRACT
Tamoxifen is the drug of choice in the treatment of breast cancer. Recent reports show an increased incidence of endometrial carcinoma in patients taking tamoxifen. In this article, we report a case of malignant mixed mullerian tumor after tamoxifen use.
